PSCR (Proto Script Pharmaceutical) Total Equity: $-1.44 Mil (As of Sep. 2017)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Proto Script Pharmaceutical Total Equity?

Proto Script Pharmaceutical PSCR Total Equity is $-1.44 Mil as of Sep. 2017.

Proto Script Pharmaceutical's total equity for the quarter that ended in Sep. 2017 was $-1.44 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Proto Script Pharmaceutical Total Equity Historical Data

* Premium members only.

The historical data trend for Proto Script Pharmaceutical's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Proto Script Pharmaceutical Total Equity Chart

Proto Script Pharmaceutical Annual Data
Trend May12 May13 May14 May15 May16
Total Equity
-0.01 0.04 0.00 -0.04 -0.08

Proto Script Pharmaceutical Quarterly Data
Nov12 Feb13 May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Sep16 Dec16 Mar17 Jun17 Sep17
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.02 -0.32 -0.83 -1.16 -1.44

Proto Script Pharmaceutical Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Proto Script Pharmaceutical's Total Equity for the fiscal year that ended in May. 2016 is calculated as

Total Equity=Total Assets(Q: May. 2016 )-Total Liabilities(Q: May. 2016 )
=0.012-0.089
=-0.08

Proto Script Pharmaceutical's Total Equity for the quarter that ended in Sep. 2017 is calculated as

Total Equity=Total Assets(Q: Sep. 2017 )-Total Liabilities(Q: Sep. 2017 )
=0.235-1.676
=-1.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $-1.44 Mil mean?
Proto Script Pharmaceutical (PSCR) has a Total Equity of $-1.44 Mil as of Sep. 2017. The total amount of equity as record on a company's balance sheet. View historical data for Proto Script Pharmaceutical and its competitors.
Is Proto Script Pharmaceutical's Total Equity too high?
Proto Script Pharmaceutical's current Total Equity is $-1.44 Mil.
How does Proto Script Pharmaceutical's Total Equity compare to EXCC and NXES?
Proto Script Pharmaceutical's Total Equity of $-1.44 Mil can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Business Services company?
A good Total Equity depends on the Business Services industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Proto Script Pharmaceutical and its competitors. Proto Script Pharmaceutical's current Total Equity is $-1.44 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Proto Script Pharmaceutical stock overvalued right now?
Proto Script Pharmaceutical (PSCR) has a current Total Equity of $-1.44 Mil. The current Total Equity is $-1.44 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Proto Script Pharmaceutical (PSCR), the current Total Equity is $-1.44 Mil as of Sep. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Proto Script Pharmaceutical Business Description

Address 9830 6th Street, Suite 103, Rancho Cucamonga, CA, USA, 91730
Proto Script Pharmaceutical Corp is primarily in the business of repair power wheelchairs and scooters, which are classified as durable medical equipment (DME) products and reimbursable by healthcare insurance providers. It has various contracts with state and governmental insurance providers, among others. These contracts provide the company with the right to sell and repair DME and its health care insurance contracts allow it the ability to service patients nationally. The group currently has its presence of repair facilities in Las Vegas, Nevada, Rancho-Cucamonga, and Anaheim, California.